Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Phase 1 Study of JADE101 in Healthy Participants
Sponsor: Jade Biosciences, Inc.
Summary
This is a Phase 1, first-in-human study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending doses of JADE101 compared to placebo in healthy participants.
Official title: A Phase 1, Randomized, Double-blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JADE101 Administered Subcutaneously in Healthy Volunteers
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
32
Start Date
2025-08-17
Completion Date
2026-10
Last Updated
2025-12-18
Healthy Volunteers
Yes
Conditions
Interventions
JADE101
JADE101 is supplied as sterile solution to be administered by SC injection.
Placebo
Placebo solution to be administered at a matching volume by SC injection.
Locations (1)
NZCR
Auckland, New Zealand